Hi Joel,
Hi Gang,
Anyone note the relative buying percentage ongoing over the past six months and who accounts for it.
See the profile at Yahoo on buying.
· Insider: 55%
· Over the last 6 months:
· 21 insider buys; 5.46M shares (27.4% of insider shares)
· Institutional: 46% (102% of float)
(32 institutions)
· Net Inst. Buying: 1.12M shares (+5.05%)
(prior quarter to latest quarter)
Then note the average daily volume.
Approx 100,000 shares...which I believe is a three month figure.
Hence outside of the Tax loss selling these guys have been loading up "SIGNIFICANTLY".
Todays News Release...
''We are grateful to Messrs. Crooks and O'Reilly for their support and contributions in transitioning the company from development to commercialization,'' said Jay D. Kranzler, M.D., Ph.D., chairman of the board and chief executive officer of Cypress, ''Our new Board members, Drs. Kessel and Rogers, are well-suited to help us take the next step -- building market awareness and use for the PROSORBA column.''
Rogers, 57, is currently president of Paramount Capital Investments and a stockholder of the company. Paramount Capital Investments is a company specializing in investments in the pharmaceutical, medical and biotechnology industries. Previously, he was the vice chancellor for health affairs at the Duke University Medical Center and served as the executive director and CEO of Duke Hospital. Dr. Rogers was formerly an Associate Dean of the Johns Hopkins University. In addition, Rogers was a founding member of ENTREMED, a biotechnology company. Rogers received a B.A. from Columbia University and an M.D. cum laude from Upstate Medical Center. He also holds an MBA from the Wharton School of Business at the University of Pennsylvania.
Kessel, 46, has a private practice in internal and geriatric medicine. He also serves as the medical director at Integrated Health Services, a conglomerate involved in geriatric care, and is a clinical instructor at Jefferson Medical College. Kessel is on the Board of Directors of PolaRx and Genta, two biotechnology companies. He holds a B.S. magna cum laude in biology from the University of Pittsburgh and a medical degree from Temple Medical School. Kessel holds board certifications in internal and geriatric medicine.
BEST WISHES
Jeffrey |
